Biochemical Reagent
-
BA6354 GW2974Summary: GW2974 is a potent dual inhibitor. -
BA6356 PKI-166Summary: PKI-166 is a highly potent and selective, orally bioactive inhibitor. -
BA6357 TheliatinibSummary: Theliatinib (Xiliertinib) is a potent, ATP-competitive, orally active and highly selective inhibitor. -
BA6359 DBPR112Summary: DBPR112 is an orally effective fluoropyrimidine-based inhibitor. -
BA6360 SelatinibSummary: Selatinib is a reversible and orally active dual and inhibitor. -
BA6361 PD-089828Summary: PD-089828 is an ATP-competitive inhibitor and a non-competitive inhibitor of tyrosine kinases. -
BA6362 IzalontamabSummary: Izalontamab (SI-B001) is a bispecific anti-monoclonal antibody with high selectivity for EGFR/HER3 heterodimers. -
BA6363 RTC-5Summary: RTC-5 (TRC-382) is an optimized phenothiazine with anticancer potency. -
BA6364 DuligotuzumabSummary: Duligotuzumab is a humanized IgG-κ monoclonal antibody. -
BA6365 BafisontamabSummary: Bafisontamab (EMB-01) is a bispecific antibody.
